Skip to main content

Advertisement

Log in

Pain assessment in premature infants treated with intravitreal antiangiogenic therapy for retinopathy of prematurity under topical anesthesia

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the physiological and behavioral pain response in premature infants receiving intravitreal bevacizumab injection (IVB) for retinopathy of prematurity (ROP) under topical anesthesia.

Methods

A prospective interventional non-comparative case series. Premature infants with high-risk prethreshold or threshold ROP received IVB using topical anesthesia with tetracaine eye drops. A Premature Infant Pain Profile was used to assess the pain response during the procedure.

Results

Nine premature infants requiring bilateral IVB therapy were included in the study. Mean gestational age was 28.7 ± 1.3 weeks, and birth weight was 1,200 ±194 grams. The mean total pain score was found to be 8.7 ± 2.4 (range 5–14), indicating generally mild pain during the procedure. Eye squeeze was the most prominent indicator of pain. Most changes occurred at the beginning, with the insertion of the lid speculum and were hardly noted during the rest of the procedure including the injection itself.

Conclusion

Topical anesthesia with tetracaine is an effective method for the relief of pain associated with intravitreal injections in premature infants with ROP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Quiroz-Mercado H, Ustariz-González O, Martinez-Castellanos MA, Covarrubias P, Dominguez F, Sanchez-Huerta V (2007) Our experience after 1765 intravitreal injections of bevacizumab: the importance of being part of a developing story. Semin Ophthalmol 22(2):109–125

    Article  PubMed  Google Scholar 

  2. Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364(7):603–615

    Article  PubMed  CAS  Google Scholar 

  3. Prenner J (2011) Anesthesia for Intravitreal injection. Retina 31(3):433–434

    Article  PubMed  Google Scholar 

  4. Blaha G, Tilton E, Barouch F, Marx J (2011) Randomized trial of anesthetic methods for intravitreal injections. Retina 31:535–539

    Article  PubMed  CAS  Google Scholar 

  5. Chen SD, Sundaram V, Wilkinson A, Patel CK (2007) Variation in anaesthesia for the laser treatment of retinopathy of prematurity—a survey of ophthalmologists in the UK. Eye 21(8):1033–1036

    Article  PubMed  CAS  Google Scholar 

  6. Stevens B, Johnson C, Taddio A (1996) Premature Infant Pain Profile: development and initial validation. Clin J Pain 12:13–22

    Article  PubMed  CAS  Google Scholar 

  7. McGee HT, Fraunfelder FW (2007) Toxicities of topical ophthalmic anesthetics. Expert Opin Drug Saf 6(6):637–640

    Article  PubMed  CAS  Google Scholar 

  8. Kandasamy Y, Smith R, Wright I, Hartley L (2011) Pain relief for premature infants during ophthalmology assessment. J AAPOS 15(3):276–280

    Article  PubMed  Google Scholar 

  9. Cogen M, Parker J, Sleep T, Elsas F, Metz T, McGwing G (2011) Masked trial of topical anesthesia for retinopathy of prematurity eye examinations. J AAPOS 15(1):45–48

    Article  PubMed  Google Scholar 

  10. Mehta M, Mansfield T, Vander Veen DK (2010) Effect of topical anesthesia and age on pain scores during retinopathy of prematurity screening. J Perinatol 30(11):731–735

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shulamit Schwartz.

Additional information

The authors have full control of all primary data, and they agree to allow Graefe's Archive for Clinical and Experimental Ophthalmology to review their data upon request.

Authors have no financial relationship with the manufacturer of any product discussed in this manuscript.

Clinical Trials Registration Number: NCT00346814

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castellanos, M.A.M., Schwartz, S., Leal, R. et al. Pain assessment in premature infants treated with intravitreal antiangiogenic therapy for retinopathy of prematurity under topical anesthesia. Graefes Arch Clin Exp Ophthalmol 251, 491–494 (2013). https://doi.org/10.1007/s00417-012-2060-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-012-2060-2

Keywords

Navigation